Genomics and Metagenomics of Asthma Severity (GEMAS)
Sponsor: Consorcio Centro de Investigación Biomédica en Red (CIBER)
This observational or N/A phase trial investigates Asthma and Asthma Attack and is currently ongoing. Consorcio Centro de Investigación Biomédica en Red (CIBER) leads this study, which shows 14 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Mar 2025 — Sep 2025 [monthly]
Unknown
-
Nov 2024 — Mar 2025 [monthly]
Unknown
-
Sep 2024 — Nov 2024 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
▶ Show 9 earlier versions
-
Jun 2024 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Mar 2023 — Jun 2024 [monthly]
Recruiting
-
Jun 2022 — Mar 2023 [monthly]
Recruiting
-
Dec 2021 — Jun 2022 [monthly]
Recruiting
-
May 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — May 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Recruiting
-
Sep 2020 — Oct 2020 [monthly]
Recruiting
First recorded
Mar 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Consorcio Centro de Investigación Biomédica en Red (CIBER)
- Hospital Doctor Jose Molina Orosa
- Hospital Donostia
- Hospital General de La Palma
- Hospital Universitario de Canarias
- Maria Pino-Yanes
- Ministry of Science and Innovation, Spain
- University Hospital of the Nuestra Señora de Candelaria
- University of La Laguna
For direct contact, visit the study record on ClinicalTrials.gov .